A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy

Although androgen deprivation therapy for prostate cancer is associated with an increased risk of osteoporosis, the optimal timing and schedule of zoledronic acid has not been identified. This phase II trial randomized 44 men beginning androgen deprivation therapy to 3 schedules of zoledronic acid a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lang, Joshua M., Wallace, Marianne, Becker, Jordan T., Eickhoff, Jens C., Buehring, Bjoern, Binkley, Neil, Staab, Mary Jane, Wilding, George, Liu, Glenn, Malkovsky, Miroslav, McNeel, Douglas G.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3836858/
https://ncbi.nlm.nih.gov/pubmed/23835291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2013.04.029
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge